Co-expression of recombinant human CYP2C9 with human cytochrome P450 reductase in protease deficient S. cerevisiae strain at a higher scale yields an enzyme of higher specific activity.

Drug metabolism letters

Volumn 4, Issue 4, 2010, Pages 246-253

  Rao, K N Purnachandra ^a   Suman, Sunil Kumar ^b   Kiran, Y Ravi ^b   Kuanr, Arup Ranjan ^b   Gupta, Anuj Kumar ^b   Bhalla, Kunal ^b   Kumar, Vipul ^b   Kundu, Prabuddha ^b   Arora, Kajal ^b   Soni, Rajeev ^b  

^a Premas Biotech Pvt Ltd   (India)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYP2C9 PROTEIN, HUMAN; CYTOCHROME B5; FLUORESCEIN; PEPTIDE HYDROLASE; RECOMBINANT PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; SULFAPHENAZOLE; UNSPECIFIC MONOOXYGENASE;

ARTICLE; BIOSYNTHESIS; DRUG ANTAGONISM; ENZYME SPECIFICITY; ENZYMOLOGY; GENETICS; HUMAN; KINETICS; METABOLISM; MICROSOME; SACCHAROMYCES CEREVISIAE;

ARYL HYDROCARBON HYDROXYLASES; CYTOCHROMES B5; FLUORESCEIN; HUMANS; KINETICS; MICROSOMES; NADPH-FERRIHEMOPROTEIN REDUCTASE; PEPTIDE HYDROLASES; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE; SUBSTRATE SPECIFICITY; SULFAPHENAZOLE;

MLCS; MLOWN;

EID: 79953321893     PISSN: 18723128     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231210792928233     Document Type: Article

References (0)